<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04326231</url>
  </required_header>
  <id_info>
    <org_study_id>PRO-003</org_study_id>
    <nct_id>NCT04326231</nct_id>
  </id_info>
  <brief_title>Cognoa Autism Spectrum Disorder (ASD) Digital Therapeutic Engagement and Usability Study</brief_title>
  <official_title>Cognoa ASD Digital Therapeutic Engagement and Usability Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cognoa, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cognoa, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cognoa will measure usability, engagement with the device, and changes in parent-reported
      socialization during a 4-week period of intervention at home with the Cognoa ASD therapeutic
      device.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 17, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Usability assessment of Cognoa ASD Therapeutic Device</measure>
    <time_frame>4 weeks</time_frame>
    <description>Device usability metrics are measured by weekly survey (e.g. ease of use for child, frustration level, fatigue).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>Cognoa ASD Therapeutic Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Usability assessment of Cognoa ASD Therapeutic Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Usability assessment of Cognoa ASD Therapeutic Device</intervention_name>
    <description>Usability assessment of Cognoa ASD Therapeutic Device</description>
    <arm_group_label>Cognoa ASD Therapeutic Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Functional English language capability in the home environment.

          -  Parent, Guardian, or legal authorized representative (LAR) must be able to read,
             understand and sign the Informed Consent Form (ICF)

          -  Female or Male, &gt; 3 to &lt; 9 years of age and parent/caregiver

          -  Diagnosis of Autism Spectrum Disorder, within the last 12 months

          -  Parent, Guardian, or legal authorized representative (LAR) must have smartphone
             capabilities for downloading Testflight software; test versions of the Cognoa for
             Child development app; and test versions of the Cognoa Digital Therapeutic app (iOS
             12.0 and up and Apple iPhone 8 and higher)

        Exclusion Criteria:

          -  Participants with any other medical, behavioral, or developmental condition that in
             the opinion of the investigator may confound study data/assessments.

          -  Participants with planned extensive travel (more than 1 week) during the course of the
             4 week intervention time period.

          -  Participants with deafness or blindness.

          -  Participants with known physical impairments affecting their ability to use their
             hands.

          -  Participants with active diagnosis of epilepsy and uncontrolled seizures.

          -  Participants whose age on the date of enrollment is outside the target age range
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kelley Abrams, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cognoa, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kelley Abrams, PhD</last_name>
    <phone>408-207-6659</phone>
    <email>kelley.abrams@cognoa.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cognoa</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94306</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelley Abrams, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 23, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2020</study_first_posted>
  <last_update_submitted>March 30, 2020</last_update_submitted>
  <last_update_submitted_qc>March 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autism Spectrum Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

